Brokerage firm Axis Direct has released its festive investment basket for the upcoming Samvat cycle, identifying nine high-conviction equity picks with projected upside potential of up to 20%. The strategy report comes after benchmark indices experienced sustained volatility, sharp intermittent pullbacks, and localized corrections throughout Samvat 2082.
According to market research published by The Economic Times, equity analysts emphasize that the breadth and sustainability of corporate earnings will serve as the primary engine for portfolio returns over the next 12 months, shifting attention away from multiple expansion toward fundamental balance-sheet strength.
Diverse Sector Selections Across Consumer, Credit, and Tech
The brokerage's festive recommendations focus on sectoral leaders demonstrating clear operational visibility, operating leverage, and demand durability despite macroeconomic crosscurrents.
In the consumer technology space, the food delivery major under coverage holds a price target of Rs 365, representing a 15% upside from recent trading levels. Axis Direct highlighted that strategic discounting designed to accelerate user acquisition and improve ordering frequency is yielding sustained platform engagement, even as EBITDA margins remain largely flat across a 1-to-2-year horizon while market reach is prioritized.
Within the financial sector, a featured banking counter has been assigned a target price of Rs 240, indicating an upside projection of 20%. Research notes indicate that the lender enters the second half of the fiscal year with strong operational momentum, expanding net interest margin (NIM) visibility, resilient asset-quality metrics, and an expected return on assets (RoA) trajectory sustained between 1% and 1.05%.
In specialized healthcare, Nephrocare secured a 20% upside projection with a target price of Rs 710. The investment case rests on structural tailwinds, including rising domestic dialysis demand, increased institutional outsourcing by hospital networks, expanding organized healthcare penetration, and steady recurring treatment revenues that bolster operational margins.
Hospitality major Indian Hotels Company Limited (IHCL) was assigned a price target of Rs 900, suggesting 15% upside potential. While aviation-linked catering under Taj-SATS faces temporary headwinds due to geopolitical air travel disruptions, IHCL's core operations remain anchored by robust premium room occupancy across Tier-1 hubs and strong performance from new portfolio openings.
In commercial transport and manufacturing, analysts set a target of Rs 170—reflecting 17% upside—supported by medium and heavy commercial vehicle (MHCV) fleet replacement cycles, market share growth in light commercial vehicles (LCV), electric vehicle initiatives, and export traction, balanced against near-term raw material input costs. In enterprise technology, IT solutions provider Coforge received an 18% upside target pegged at Rs 2,245, supported by steady multi-year execution.
Key Diwali Recommendations Overview
| Company / Stock Segment | Target Price (INR) | Projected Upside (%) | Primary Catalyst Identified |
|---|---|---|---|
| Banking Pick | Rs 240 | 20% | RoA expansion (1–1.05%), NIM visibility, healthy asset quality |
| Nephrocare | Rs 710 | 20% | Dialysis outsourcing growth, recurring clinical revenues |
| IT Services (Coforge) | Rs 2,245 | 18% | Multi-year execution stability, structural digital demand |
| Commercial Vehicles | Rs 170 | 17% | MHCV fleet replacement, export growth, EV diversification |
| Consumer Tech / Food Delivery | Rs 365 | 15% | Customer acquisition scale, sustained platform frequency |
| Indian Hotels (IHCL) | Rs 900 | 15% | Tier-1 occupancy strength, select-service portfolio expansion |
Strategic Takeaways for Retail and Institutional Investors
Market participants navigating the start of the new Samvat year face an environment where broad-based index rallies have yielded to stock-specific price discovery. Market documentation compiled via ET Markets notes that institutional allocations increasingly prioritize companies with proven operating leverage and balance sheet flexibility over high-valuation momentum plays.
Investors entering festive positions should balance projected return targets against ongoing macroeconomic risks, including commodity price swings, central bank monetary trajectories, and volatile international demand patterns throughout the fiscal year.
